CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: a randomized, placebo-controlled trial T Masonou, DA Hokey, T Lahey, A Halliday, LC Berrocal-Almanza, ... PLoS One 14 (5), e0217091, 2019 | 23 | 2019 |
Cell-intrinsic differences between human airway epithelial cells from children and adults EF Maughan, RE Hynds, A Pennycuick, E Nigro, KHC Gowers, C Denais, ... Iscience 25 (11), 2022 | 15 | 2022 |
Immunodiagnosis of active tuberculosis A Halliday, T Masonou, M Tolosa-Wright, V Mandagere, A Lalvani Expert review of respiratory medicine 13 (6), 521-532, 2019 | 15 | 2019 |
Human models for COVID‐19 research MNJ Woodall, T Masonou, KM Case, CM Smith The Journal of Physiology 599 (18), 4255-4267, 2021 | 14 | 2021 |
Age-specific nasal epithelial responses to SARS-CoV-2 infection MNJ Woodall, AM Cujba, KB Worlock, KM Case, T Masonou, M Yoshida, ... Nature microbiology 9 (5), 1293-1311, 2024 | 8 | 2024 |
New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ... Efficacy and Mechanism Evaluation 8 (5), 2021 | 4 | 2021 |
IL-1β turnover by the UBE2L3 ubiquitin conjugating enzyme and HECT E3 ligases limits inflammation V Mishra, A Crespo-Puig, C McCarthy, T Masonou, I Glegola-Madejska, ... Nature Communications 14 (1), 4385, 2023 | 3 | 2023 |
The emergence of goblet inflammatory or ITGB6hi nasal progenitor cells determines age-associated SARS-CoV-2 pathogenesis M Woodall, AM Cujba, KB Worlock, KM Case, T Masonou, M Yoshida, ... bioRxiv, 2023.01. 16.524211, 2023 | 2 | 2023 |
Defining the role of cellular immune signatures in diagnostic evaluation of suspected tuberculosis A Halliday, T Masonou, MR Tolosa-Wright, Y Guo, L Hoang, R Parker, ... The Journal of Infectious Diseases 225 (9), 1632-1641, 2022 | 2 | 2022 |
Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients S Ellis, R Way, M Nel, A Burleigh, I Doykov, J Kembou-Ringert, M Woodall, ... Mucosal Immunology 17 (1), 124-136, 2024 | 1 | 2024 |
IL-1β turnover by TRIP12 and AREL1 ubiquitin ligases and UBE2L3 limits inflammation V Mishra, A Crespo-Puig, C McCarthy, T Masonou, I Glegola-Madejska, ... bioRxiv, 2022.09. 14.507790, 2022 | | 2022 |
Investigating neutrophil function during SARS-CoV2 infection in human airway epithelial cells from elderly and young individuals T Masonou, M Woodall, E Robinson, A Eddaoudi, KM Case, JO Canseco, ... European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
Longevity and neutralisation activity of secretory IgA following SARS-CoV-2 infection S Ellis, A Burleigh, R Way, J Kembou-Ringert, T Masonou, K Gilmour, ... Access Microbiology 4 (5), po0272, 2022 | | 2022 |
Cellular immune signatures A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ... New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study, 2021 | | 2021 |
Transcriptomics A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ... New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study, 2021 | | 2021 |
Candidate rule-out tests A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ... New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study, 2021 | | 2021 |
Health economic analysis A Halliday, P Jain, L Hoang, R Parker, M Tolosa-Wright, T Masonou, ... New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study, 2021 | | 2021 |
Differential spatiotemporal targeting of Toxoplasma and Salmonella by GBP1 assembles caspase signalling platforms D Fisch, B Clough, MC Domart, H Bando, T Masonou, LM Collinson, ... | | 2019 |
Validation of New Technologies for the Diagnostic Evaluation of Active Tuberculosis (VANTDET) A Halliday | | 2018 |
Remdesivir and Nirmatrelvir Show Consistent Synergistic Efficacy Across Ancestral and Newly Emerged Sars-Cov-2 Clinical Isolates M Woodall, S Ellis, S Zhang, J Kembou-Ringert, KA Kite, L Buggiotti, ... Available at SSRN 4853574, 0 | | |